The global dried blood spot collection cards market size is expected to reach USD 337.3 million by the year 2026, expanding at a CAGR of 3.5%, according to a new report by Grand View Research, Inc. Key drivers of the market include an increase in the use of dried blood spot (DBS) cards in newborn screening and for serological diagnostics of infectious and autoimmune diseases, among other applications.
Use of DBS cards in newborn screening is expected to boost market growth during the forecast period. According to NIH, it is estimated that around 4 million infants were screened in the U.S. in 2017. Additionally, data from the CDC indicates that about 12,500 infants were diagnosed with congenital diseases that were detected through newborn screening tests. This states that almost 1 out of every 300 infants screened were eventually diagnosed with one of the congenital diseases. Therefore, increasing awareness has facilitated a rise in demand for DBS cards for the detection of congenital diseases in infants which is anticipated to fuel the market growth during the forecast period.
The usage of DBS for serological diagnostics of infectious or autoimmune diseases is also anticipated to fuel the market growth during the forecast period. DBS offers a cost-effective solution for diagnosis of infectious diseases as these collection cards can be easily collected, transported and preserved in settings with minimal infrastructural facilities. Global health settings, especially in the rural areas, lack the necessary infrastructure for quality assured venipuncture sparks significant interest in the usage of DBS cards for diagnosis of infectious or autoimmune diseases.
Various initiatives and strategic collaborations are expected to further drive dried blood spot collection cardsmarket growth. For instance, in February 2019, Health PEI announced the launch of its first blood spot testing clinic for hepatitis C and HIV. In the recent past, Health PEI partnered with PEERS Alliance in order to offer new hepatitis C clinics. Also, in July 2017, AIDS PEI announced the launch of free hepatitis C tests on World Hepatitis Day. Public Health England offers a national dried blood spot testing service for newborns born to hepatitis B positive mothers. This service provided by PHE is free and has been specially designed to improve the coverage of follow up testing for newborns of hepatitis B positive mothers. Similarly, in October 2019, World Anti-Doping Agency signed an agreement with 7 anti-doping agencies that include the U.S. Anti-Doping Agency (USADA) to explore the viability of DBS testing as part of its anti-doping tool kit. The objective of this project was to develop guidelines for the transport, collection, storage, and analysis of DBS. This method will be implemented at the 2020 Tokyo Summer Olympics. The usage of DBS in these settings offer several advantages such as; the presence of a phlebotomist to administer the test and the samples do not require a temperature-controlled environment. These are less invasive and are simpler than intravenous blood testing. Thus, the rise in government initiatives to enhance the usage of DBS is witnessed to propel the market growth during the forecast period.
In August 2017, PerkinElmer launched PerkinElmer Genetics’ clinical genomics services. Whole exome sequencing and whole-genome sequencing were offered in all their laboratories across India, U.S., and China. PerkinElmer’s genome lab testing platform offers diagnostic testing and screening, newborn screening using dried blood spot cards and generation sequencing of rare inherited diseases. Therefore, the increase in strategic initiatives undertaken by major market players is expected to increase the demand and usage of DBS cards for newborn screening during the forecast period.
Request a Sample Copy of the Global Dried Blood Spot Collection Cards Market Research Report @ https://www.grandviewresearch.com/industry-analysis/dried-blood-spot-collection-cards-market/request/rs1
Further Key Findings from the Report Suggest:
- Newborn screening is expected to witness exponential growth during the forecast period owing to various advantages such as its rapid turn-around times, ability to be stored at any ambient conditions, minimally invasive nature of the tests, and requirement of small quantities of blood collection
- Whatman 903 blood collection cards are also anticipated to propel the market growth during the forecast period as they provide an efficient and safe method for easy sample identification, collection, and transport
- The Asia Pacific region is expected to witness the highest growth during the forecast period owing to the rise in the incidence of hepatitis C, HIV, and other infectious diseases
- Major players catering to the dried blood spot collection cardsmarket are Qiagen; PerkinElmer; Roche; Shimadzu Corporation; Novilytic Labs; Ahlstrom-Munksjö; Pall Corporation; Eastern Business Forms, Inc.; ARCHIMEDlife; and Centogene AG, among others
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/6911/ibb
Grand View Research has segmented the global dried blood spot collection cards market on the basis of application, card type, and region:
Dried Blood Spot Collection Cards Application Outlook (Revenue, USD Million, 2015 – 2026)
- Newborn Screening (NBS)
- Infectious Diseases Testing
- Therapeutic Drug Monitoring
- Other Applications
Dried Blood Spot Collection Cards Card Type Outlook (Revenue, USD Million, 2015 – 2026)
- Whatman 903
- Ahlstrom 226
Dried Blood Spot Collection Cards Regional Outlook (Revenue, USD Million, 2015 – 2026)
- North America
- Asia Pacific
- South Korea
- Latin America
- South Africa
- Saudi Arabia
Browse Related Reports @
Blood Collection Market: https://www.grandviewresearch.com/industry-analysis/blood-collection-market
Lateral Flow Assay Market: https://www.grandviewresearch.com/industry-analysis/lateral-flow-assay-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States